![Xiang Yang Lu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiang Yang Lu
Directeur Général chez
LAEKNA, INC.
Fortune : 41 M $ au 30/06/2026
Profil
Xiang Yang Lu is the founder of Laekna Therapeutics (Shanghai) Co., Ltd., founded in 2016, serving as Chief Executive Officer & Director.
Dr. Lu is the founder of Laekna, Inc., founded in 2016, serving as Chairman & Chief Executive Officer.
Current jobs include Director at Laekna Ltd. and Independent Non-Executive Director at Sirius Therapeutics.
Former jobs include Executive Director at Novartis Institutes for Biomedical Research, Inc. from 2003 to 2016, Executive Director at China Novartis Institutes for BioMedical Research Co., Ltd. from 2003 to 2016, and Venture Partner at Frontline Bioventures.
Education includes a doctorate from The University of North Carolina at Chapel Hill conferred in 1995, a graduate degree from Nankai University conferred in 1988, and an undergraduate degree from Nankai University conferred in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LAEKNA, INC. 10,6 % | 08/07/2026 | 47 609 916 ( 10,6 % ) | 41 M $ | 30/06/2026 |
Postes actifs de Xiang Yang Lu
| Sociétés | Poste | Début |
|---|---|---|
| LAEKNA, INC. | Directeur Général | 29/07/2016 |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs | Fondateur | 01/12/2016 |
Laekna Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Xiang Yang Lu
| Sociétés | Poste | Fin |
|---|---|---|
China Novartis Institutes for BioMedical Research Co., Ltd. | Directeur/Membre du Conseil | 01/03/2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Directeur/Membre du Conseil | 01/03/2016 |
Frontline Bioventures
 Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
Formation de Xiang Yang Lu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Finance |
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs | Health Technology |
China Novartis Institutes for BioMedical Research Co., Ltd. | |
Laekna, Inc.
 Laekna, Inc. BiotechnologyHealth Technology Operates as an clinical-stage global biotechnology company | Health Technology |
Laekna Ltd. |
